Roland Magnusson AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) said on Thursday that their medicine datopotamab deruxtecan (Dato-DXd) showed durable efficacy in patients with a type of breast cancer in an early stage study. The two-part, phase 1 trial, dubbed TROPION-PanTumor01, is evaluating datopotamab deruxtecan in patients with advanced solid […]
Promise
LinkedIn #B2Believe and The Playbook for Promise Making in B2B Marketing with Jim Habig
Selfie with Tusar Barik & Jim Habig of LinkedIn at #b2believe How can marketers put promise making into practice? LinkedIn Vice President of Marketing, Jim Habig, shared the keys to the power of storytelling, the importance of creativity, and the exciting opportunity ahead for B2B marketers at LinkedIn’s inaugural B2B […]